contraindications for glp-1 agonists Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs Emergency Presentations of GLP-1 Agonist
Description
doi: 10.1016/S0140-6736(18)32260-8 [DOI] [PubMed] [Google Scholar] 190.Rosenstock J, Wysham C, Fras JP, et al
J.LiY.KwanE.BrownT
Stopping the medication often leads to weight regain for patients if permanent lifestyle changes were not made
Additionally, patients taking multiple medications should be evaluated for potential drug interactions or additive effects, particularly if they are also taking statins, which have well-established myopathic potential
